PT Diagnos Laboratorium Utama Tbk (DGNS.JK)

IDR 138.0

(0.73%)

Market Cap (In IDR)

172.5 Billion

Revenue (In IDR)

145.69 Billion

Net Income (In IDR)

-13.65 Billion

Avg. Volume

10.6 Million

Currency
IDR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
188.0-436.0
PE
2.66
EPS
51.842
Beta Value
0.439
ISIN
ID1000158702
CUSIP
-
CIK
-
Shares
1250000000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Engineer Mesha Rizal Sini
Employee Count
-
Website
https://diagnos.co.id
Ipo Date
2021-01-15
Details
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; anatomical pathology laboratory tests for examination of tissues and/or body fluids; and genomics laboratory tests comprising non-invasive prenatal testing, preimplantation genetic testing for aneuploidy services, and preimplantation genetic testing for monogenic diseases services. It also offers homecare health services for health checks that can be done at home; corporate health services; and covid-19 check-up services, as well as health care activities managed by the government and the private sector, such as pharmacy warehouses, eye banks, blood banks, sperm banks, organ transplant banks, and other health care services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.